Systematic analysis of large screening sets in drug discovery.
about
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher diseaseCdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.High-throughput screening based identification of small molecule antagonists of integrin CD11b/CD18 ligand binding.Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts.Taking Advantage of Databases.Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1.
P2860
Systematic analysis of large screening sets in drug discovery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Systematic analysis of large screening sets in drug discovery.
@en
Systematic analysis of large screening sets in drug discovery.
@nl
type
label
Systematic analysis of large screening sets in drug discovery.
@en
Systematic analysis of large screening sets in drug discovery.
@nl
prefLabel
Systematic analysis of large screening sets in drug discovery.
@en
Systematic analysis of large screening sets in drug discovery.
@nl
P2093
P356
P1476
Systematic analysis of large screening sets in drug discovery.
@en
P2093
Chihae Yang
Glenn J Myatt
Joseph S Verducci
Kevin P Cross
Michael A Fligner
Paul E Blower
P356
10.2174/1570163043484879
P577
2004-01-01T00:00:00Z